Anne Marie Woodland
Senior Vice President of Regulatory Affairs and Qu
Healthcare Experts
Replimune
Spain
Biography
Annie Woodland most recently had regulatory responsibility for all early stage and commercial products at uniQure Inc. Prior to joining uniQure, Annie was Executive Director and Global Regulatory Lead for T-VEC at Amgen/Biovex. She has extensive regulatory and quality expertise in the biopharmaceutical industry, specifically the areas of gene therapy and biologics and has held positions at CombinatoRx, Inc, Dyax Corp., Curis, Inc. (previously Reprogenesis), T-Cell Diagnostics and Baxter Dade.
Research Interest
biologics gene therapy
